Akers withdraw its application for PIFA CHlamydia AKR.L
Akers Biosciences has decided to withdaw its initial 510(k) application for PIFA Chlamydia in order to re-evaluate its options with…
Pharmaceuticals, Biotechnology and Life Sciences
Akers Biosciences has decided to withdaw its initial 510(k) application for PIFA Chlamydia in order to re-evaluate its options with…
The U.S. Food and Drug Administration (FDA) has accepted Bayer’s partner’s Loxo Oncology’s New Drug Application (NDA), and granted Priority…
Novartis has gotten new evidence from the CHAMP-HF registry comparing Entresto patients to patients not taking Entresto, which showed that…
The U.S. Food and Drug Administration has issued a warning about the over-the-counter (OTC) teething products containing benzocaine pose a…
AstraZeneca and MedImmune, its global biologics research and development arm, on Friday reported positive overall survival (OS) results for the…
The U.S. Food and Drug Administration has approved AkaRx’s Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with…
Eli Lilly said Thursday its senior vice president and president of Lilly Oncology, and the member of the company’s executive…
Novartis’s Sandoz has secured European Commission’s approval for biosimilar Zessly, the company said Thursday.
People treated with Saxenda for weight management lost an average of 8.1 kg after six months in a real-world clinical…
Eli Lilly said Tuesday that the U.S. Food and Drug Administration (FDA) has approved a label update for Taltz injection 80 mg/mL to…